ITR recognizes Deloitte for achievement in tax innovation, technology, ESG and DEI Deloitte announced today that it has received four awards at the 2024 International Tax Review (ITR) Americas Tax Awards, honoring its accomplishments delivering market-leading services and solutions. Deloitte was named “ESG Firm of the Year” and “Diversity Equity & Inclusion Firm of the […]

Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE™ Pulsed Field Ablation (PFA) System. The FARAPULSE PFA System, which is indicated for the isolation of pulmonary veins in the treatment of paroxysmal atrial fibrillation (AF), is a novel alternative to standard-of-care thermal ablation

SenseRobot, an artificial intelligence (AI) home robotics brand,has unveileda new addition to its AI-powered chess robot series, SenseRobot Chess.SenseRobot Chess has achieved a significant breakthrough, mastering complex engineering challenges that allow its intelligent robotic arms to precisely grasp and position 3D chess pieces — marking a first in household robotics. Chess players cannowenjoy an immersive

LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (“LakeShore Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the results of its extraordinary general meeting (the “EGM”) held on September 27, 2024 (Beijing Time) virtually via a

Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2024[1]. 2024 First Half Highlights — Total net revenues were RMB218.8 million (US$30.1 million) in the

— Clinically meaningful improvements observed with BIMZELX over one year of treatment were maintained up to two years (Week 96) — At Week 96, over eight in 10 patients treated with BIMZELX achieved HiSCR50, over seven in 10 achieved HiSCR75, and over four in 10 achieved HiSCR100* — Approximately one in three patients treated with

Katrina E. Bell-Jordan, Ph.D. will be inaugurated Oct. 4. Celebratory activities to be held Oct. 3-5. Northeastern Illinois University (NEIU) will celebrate the inauguration of its eighth president, Katrina E. Bell-Jordan, Ph.D., with three days of activities from Oct. 3-5, 2024. The theme of the inauguration festivities is “Education, Excellence and Empowerment.” “We invite our

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of life COPD is the most prevalent chronic respiratory disease in China, and is a priority within the government’s

BEIJING, Sept. 27, 2024 (GLOBE NEWSWIRE) — Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a leading provider of digital educational content in China, today announced its financial results for six months ended June 30, 2024. Revenue decreased by 25.4% from RMB280.6 million for the six months ended June 30, 2023

New patent expected to provide market exclusivity into 2036 Zembrace(R) SymTouch(R) (sumatriptan succinate injection) 10mg is indicated for the acute treatment of migraine in adults CHATHAM, N.J., Sept. 27, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development